Transmedics Group Inc at Morgan Stanley Global Healthcare Conference Transcript
Thank you, everybody, for joining us. Patrick Wood, I run the U.S. med tech team here. I get an exciting disclosure to you before we start, which is, please see Morgan Stanley Research disclosures website, morganstanley.com, research disclosures. I'm sure all of you will be going there. Any questions, feel free to reach out to your sales rep. And with that, very excited to have Waleed Hassanein and Stephen Gordon, CEO and CFO of TransMedics, respectively, for what should be a really fun discussion for outside chat. I'm sure you're all familiar with TransMedics. And for those of you who on, it's a super interesting story.
Questions & Answers
And so maybe if we kick it off, I think the 2023 guidance and '24, it implies a slight slowdown in the second half of the year. I mean is it realistic to say that some of that's maybe a little bit of conservatism or are you seeing something
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
